100 related articles for article (PubMed ID: 10595646)
21. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
22. Fenofibrate inhibits thrombogenic and fibrinolytic factors expression in adipose tissue of atherosclerotic rabbits.
Zhao SP; Li J; Xu Z; Wu J; Li Q; Ye H
Clin Chim Acta; 2004 Nov; 349(1-2):81-6. PubMed ID: 15469859
[TBL] [Abstract][Full Text] [Related]
23. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
He HY; Wang C; Pang BS
Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
26. Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1.
Montes R; Declerck PJ; Calvo A; Montes M; Hermida J; Muñoz MC; Rocha E
Thromb Haemost; 2000 Jul; 84(1):65-70. PubMed ID: 10928472
[TBL] [Abstract][Full Text] [Related]
27. Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value.
Hundsdorfer B; Zeilhofer HF; Bock KP; Dettmar P; Schmitt M; Kolk A; Pautke C; Horch HH
J Craniomaxillofac Surg; 2005 Jun; 33(3):191-6. PubMed ID: 15878520
[TBL] [Abstract][Full Text] [Related]
28. Immunological relationship between plasminogen activator inhibitors from different sources.
Urdén G; Chmielewska J; Carlsson T; Wiman B
Thromb Haemost; 1987 Feb; 57(1):29-34. PubMed ID: 2438797
[TBL] [Abstract][Full Text] [Related]
29. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
[TBL] [Abstract][Full Text] [Related]
30. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
Pawlowska Z; Pluskota E; Chabielska E; Buczko W; Okruszek A; Stec WJ; Cierniewski CS
Thromb Haemost; 1998 Feb; 79(2):348-53. PubMed ID: 9493589
[TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of the uPa/PAI-1 complex in breast cancer.
Sten-Linder M; Seddighzadeh M; Engel G; Rutqvist LE; Linder S; Skoog L; Wima B
Anticancer Res; 2001; 21(4B):2861-5. PubMed ID: 11712777
[TBL] [Abstract][Full Text] [Related]
32. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
33. [The plasma levels of urokinase plasminogen activator and urokinase plasminogen activator receptor and plasminogen activator inhibitor-1 in patients with different stages of liver cirrhosis following chronic hepatitis B].
Wu XR; Wang Q; Shi SS; Lu MH; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):82-4. PubMed ID: 14980106
[TBL] [Abstract][Full Text] [Related]
34. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
Green J; Doughty L; Kaplan SS; Sasser H; Carcillo JA
Thromb Haemost; 2002 Feb; 87(2):218-23. PubMed ID: 11858480
[TBL] [Abstract][Full Text] [Related]
35. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.
Declerck PJ; Alessi MC; Verstreken M; Kruithof EK; Juhan-Vague I; Collen D
Blood; 1988 Jan; 71(1):220-5. PubMed ID: 3257145
[TBL] [Abstract][Full Text] [Related]
36. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
37. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivo.
Van De Craen B; Scroyen I; Abdelnabi R; Brouwers E; Lijnen HR; Declerck PJ; Gils A
Thromb Res; 2011 Jul; 128(1):68-76. PubMed ID: 21392818
[TBL] [Abstract][Full Text] [Related]
39. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
